Table 1.
Worldwide human papilloma virus coverages among female population aged 10–20 years, the cervical cancer incidence (by continent), and the health care systems (by countries).
| Geographical region | HPV vaccine coverage | Cervical cancer incidence (cumulative risk 0–74) (%) | |
|---|---|---|---|
| Africa | 1.2% (0.6–2.0) | Eastern Africa | 4.34 |
| Middle Africa | 3.02 | ||
| Northern Africa | 0.82 | ||
| Southern Africa | 4.20 | ||
| Western Africa | 3.47 | ||
|
| |||
| Asia | 1.2% (0.7–1.8) | Eastern Asia | 1.09 |
| South-Eastern Asia | 1.86 | ||
| South-Central Asia | 1.41 | ||
| Western Asia | 0.45 | ||
|
| |||
| Europe | 36.4% (30.3–42.9) | Central and Eastern Europe | 1.58 |
| Western Europe | 0.66 | ||
| Southern Europe | 0.77 | ||
| Northern Europe | 0.85 | ||
|
| |||
| Latin America and Caribbean | 22.1% (12.7–32.6) | Caribbean | 1.54 |
| Central America | 1.32 | ||
| South America | 1.56 | ||
|
| |||
| North America | 53.4% (27.1–85.6) | North America | 0.62 |
|
| |||
| Oceania | 41.1% (21.5–64.0) | Australia and New Zealand | 0.55 |
| Melanesia | 2.60 | ||
| Polynesia | 1.16 | ||
| Micronesia | 2.03 | ||
Data in parentheses are 95% confidence interval.